InvestorsHub Logo
Followers 0
Posts 1326
Boards Moderated 0
Alias Born 01/25/2016

Re: EOT post# 41356

Wednesday, 11/21/2018 10:27:18 AM

Wednesday, November 21, 2018 10:27:18 AM

Post# of 113781
To all who believe Adva27a will ever fight/destroy anything, other than your portfolios......

Back in 2011, “Data published in our issued and pending patent applications have shown that Adva-27a is three times more effective in arresting cancer cell growth than its current market competitor,” according to Steve Slilaty, Sunshine’s president and CEO. “We anticipate completion by the first half of 2012, and if things go as we expect we anticipate Adva-27a to be available for compassionate use by the end of the trial."

Wow, almost 7yrs, same BS story. Zero progress. How many more companies do they have to go through, before they admit it's a complete failure? Wonder why Binghamton university pulled the plug?? Colleges get all sorts of Grant's and research money.......love to get feedback/results from an independent group on this so called cancer drug/hypothesis.

Source: https://www.genengnews.com/topics/drug-discovery/the-research-foundation-of-suny-to-help-sunshine-biopharma-push-anticancer-agent-into-the-clinic/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News